v3.26.1
Acquisitions, Dispositions, and Funded Research and Development Arrangements - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Apr. 24, 2026
Apr. 24, 2026
Apr. 25, 2025
Apr. 26, 2024
Business Combination [Line Items]        
Fair value of contingent consideration $ 163 $ 163 $ 81 $ 149
Other operating expense, net   386 (23) 464
Other accrued expenses 3,634 3,634 3,683  
Other liabilities 2,055 2,055 1,769  
Revenue   $ 142 181 174
Collaborative arrangement, revenue not from contract with customer, statement of income or comprehensive income [Extensible Enumeration]   Other operating expense, net    
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement        
Business Combination [Line Items]        
Milestone payments 1,200 $ 1,200    
Other operating expense, net 157      
Additional funding 249 249    
Level 3        
Business Combination [Line Items]        
Contingent consideration receivable 0 0 13 $ 58
Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesCurrent        
Business Combination [Line Items]        
Fair value of contingent consideration 32 32 31  
Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesNoncurrent        
Business Combination [Line Items]        
Fair value of contingent consideration $ 131 $ 131 $ 50